2.3. Palmitic acid and drug treatments

CT Changhong Tan
XL Xi Liu
WP Wuxue Peng
HW Hui Wang
WZ Wen Zhou
JJ Jin Jiang
XW Xin Wei
LM Lijuan Mo
YC Yangmei Chen
LC Lifen Chen
request Request a Protocol
ask Ask a question
Favorite

Cultured neurons were treated with 0, 50, 100, 200 or 500 μmol/L palmitic acid (PA) (P5585; Sigma‐Aldrich) and 1 mmol/L l‐carnitine (LC) (C0158; Sigma‐Aldrich) for 8 hours to establish the appropriate concentration of PA. Neuronal viability was measured as described below. A 100 μmol/L PA treatment was chosen for further experiments assessing KB production. Briefly, LC was dissolved in PBS (1 mol/L). PA stock solutions of 200 mmol/L were prepared in 100% ethanol. Working solutions of 6 mmol/L PA were generated by incubating the PA in PBS containing 10% endotoxin‐free and fatty acid‐free bovine serum albumin at 37°C for 60 minutes. This solution was then added to the media and incubated for 8 hours before KB measurements.

All drugs were dissolved in DMSO. Neurons were incubated with 10 μmol/L pioglitazone (M3283; Abmole, Houston, TX, USA), 10 μmol/L GW9662 (M2748; Abmole) or 5 μmol/L apoptozole (M7575; Abmole) for 24 hours before further experiments. Neurons treated with an equal amount of DMSO served as controls.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A